Literature DB >> 24845519

Dietary supplementation of Pediococcus pentosaceus enhances innate immunity, physiological health and resistance to Vibrio anguillarum in orange-spotted grouper (Epinephelus coioides).

Jian-Bin Huang1, Yu-Chi Wu1, Shau-Chi Chi2.   

Abstract

Groupers (Epinephelus spp.) are economically important fish species in Southeast Asian aquaculture. Vibriosis caused by Vibro spp. is one of the severe bacterial diseases that devastate the grouper aquaculture industry. Probiotics have been reported to show the potential to enhance fish immunity and to antagonize pathogens. In our previous study, a lactic acid bacterium Pediococcus pentosaceus strain 4012 (LAB4012), isolated from cobia intestine, protects cobia from photobacteriosis after a 2-week feeding. In this study, we examined the potential of LAB4012 to be a probiotic for the orange-spotted grouper through feeding, thus to guard against vibriosis. In vitro, LAB4012 culture supernatant with low pH suppressed the growth of Vibrio anguillarum, and lactic acid in the metabolite of LAB4012 appeared to be the major factor to the growth inhibition of V. anguillarum. In vivo, the challenge test showed that the cumulative mortality of the LAB4012-fed groupers was significantly lower than that of the control fish after V. anguillarum infection. Supplementation of LAB4012 in commercial diet not only enhanced the growth rate and erythrocyte numbers of the groupers, but also regulated the gene expression of the pro-/anti-inflammatory cytokines. One day post-infection of V. anguillarum, the leukocyte numbers in the peripheral blood and the phagocytic activity of the head-kidney phagocytes in the LAB4012-fed groupers were found significantly increased, when compared with those without LAB4012-feeding. These results suggested that LAB4012 can be a dietary probiotic for groupers in modulating the immunity and protecting the groupers from V. anguillarum infection.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Grouper; Lactic acid bacteria; Pediococcus pentosaceus; Probiotics; Vibrio

Mesh:

Substances:

Year:  2014        PMID: 24845519     DOI: 10.1016/j.fsi.2014.05.003

Source DB:  PubMed          Journal:  Fish Shellfish Immunol        ISSN: 1050-4648            Impact factor:   4.581


  7 in total

Review 1.  Mechanisms Used by Probiotics to Confer Pathogen Resistance to Teleost Fish.

Authors:  Rocío Simón; Félix Docando; Noelia Nuñez-Ortiz; Carolina Tafalla; Patricia Díaz-Rosales
Journal:  Front Immunol       Date:  2021-04-27       Impact factor: 7.561

Review 2.  The Gut Microbiota of Marine Fish.

Authors:  Sian Egerton; Sarah Culloty; Jason Whooley; Catherine Stanton; R Paul Ross
Journal:  Front Microbiol       Date:  2018-05-04       Impact factor: 5.640

Review 3.  Pediococcus pentosaceus, a future additive or probiotic candidate.

Authors:  Shiman Jiang; Lingzhi Cai; Longxian Lv; Lanjuan Li
Journal:  Microb Cell Fact       Date:  2021-02-16       Impact factor: 5.328

Review 4.  Vibriosis Outbreaks in Aquaculture: Addressing Environmental and Public Health Concerns and Preventive Therapies Using Gilthead Seabream Farming as a Model System.

Authors:  Gracinda M M Sanches-Fernandes; Isabel Sá-Correia; Rodrigo Costa
Journal:  Front Microbiol       Date:  2022-07-11       Impact factor: 6.064

Review 5.  Probiotics as Means of Diseases Control in Aquaculture, a Review of Current Knowledge and Future Perspectives.

Authors:  Seyed Hossein Hoseinifar; Yun-Zhang Sun; Anran Wang; Zhigang Zhou
Journal:  Front Microbiol       Date:  2018-10-12       Impact factor: 5.640

Review 6.  Lactic Acid Bacteria in Finfish-An Update.

Authors:  Einar Ringø; Seyed Hossein Hoseinifar; Koushik Ghosh; Hien Van Doan; Bo Ram Beck; Seong Kyu Song
Journal:  Front Microbiol       Date:  2018-08-10       Impact factor: 5.640

7.  Pediococcus acidilactici P25 Protected Caenorhabditis elegans against Enterotoxigenic Escherichia coli K88 Infection and Transcriptomic Analysis of Its Potential Mechanisms.

Authors:  Keqin Tan; Dun Deng; Xianyong Ma; Yiyan Cui; Zhimei Tian
Journal:  Biomed Res Int       Date:  2020-03-30       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.